Joseph Chazen, MD
Diagnostic Radiology · New York, NYNPI 1306098520
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $658 of the $990 with a category attached, or 66.4%. 3 manufacturers reported payments, led by Relievant Medsystems, Inc. at 41.8% of the total. Reporting peaked in 2021 at $414 and has fallen 59.9% since, to $166 in 2025.
Across 8 payments — averaging $123.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$414
- Boston Scientific$402
- Stryker$175
Across 1 payment — averaging $77,677 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$78K
What the payments were for
- Travel & lodging$33334%
- Food & beverage$65866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 4 | $414 |
| Boston Scientific | 3 | $402 |
| Stryker | 1 | $175 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$947
- AUGMENT INJECTABLE$175
How this compares
$990 in reported general payments places this provider in the 85th percentile of 2,530 diagnostic radiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in New York
- Thomas SosNew York$3.5M
- Lawrence TanenbaumNew York$1.5M
- Gregory SicaNew York$496K
- Marc BrownNew York$435K
- Mark WestcottNew York$420K
- Mark FrancesconeNew York$291K
- John CarrinoNew York$276K
- Lawrence SchwartzNew York$269K
- Kambiz NaelNew York$229K
- Bachir TaouliNew York$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.